Atrial Fibrillation in Cancer Patients: Who is at Risk?
Cancer is the second leading cause of mortality in the world, second only to cardiovascular diseases. Simultaneously cancer mortality has been steadily decreasing due to the development of new chemotherapy and targeted drugs and the improvement of existing treatment protocols. Improving the pr...
मुख्य लेखकों: | , , , , |
---|---|
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
Столичная издательская компания
2022-01-01
|
श्रृंखला: | Рациональная фармакотерапия в кардиологии |
विषय: | |
ऑनलाइन पहुंच: | https://www.rpcardio.online/jour/article/view/2619 |